Tyra Biosciences Files 2024 10-K
Ticker: TYRA · Form: 10-K · Filed: Mar 27, 2025 · CIK: 1863127
| Field | Detail |
|---|---|
| Company | Tyra Biosciences, Inc. (TYRA) |
| Form Type | 10-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, financials
TL;DR
Tyra Bio's 2024 10-K is in. Check financials and risks.
AI Summary
Tyra Biosciences, Inc. filed its 2024 10-K on March 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, focused on pharmaceutical preparations, is incorporated in Delaware and headquartered in Carlsbad, California. Key financial activities and disclosures for the period are detailed within the filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Tyra Biosciences' financial performance, operational status, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Tyra Biosciences faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-27 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Tyra Biosciences, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-27 (date) — Filing date
- Carlsbad, CA (location) — Company headquarters
- 0001863127 (company) — Central Index Key
FAQ
What is Tyra Biosciences' primary business activity?
Tyra Biosciences, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code [2834].
When did Tyra Biosciences file its 10-K for the fiscal year ending December 31, 2024?
Tyra Biosciences, Inc. filed its 10-K on March 27, 2025.
Where is Tyra Biosciences, Inc. headquartered?
The company's business address is listed as 2656 State Street, Carlsbad, CA 92008.
What is the SEC file number for Tyra Biosciences?
The SEC file number for Tyra Biosciences is 001-40800.
What types of securities were involved in a private placement for Tyra Biosciences during the reporting period?
During the period from January 1, 2024, to December 31, 2024, Tyra Biosciences engaged in a private placement of its Common Stock.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding Tyra Biosciences, Inc. (TYRA).